{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:13:04Z","timestamp":1772539984273,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Department of Health & Human Services | U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["FDA Perinatal Health Center of Excellence (PHCE) grant #GCBER00"],"award-info":[{"award-number":["FDA Perinatal Health Center of Excellence (PHCE) grant #GCBER00"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL146936"],"award-info":[{"award-number":["K23HL146936"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL150244"],"award-info":[{"award-number":["K23HL150244"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23HD096018"],"award-info":[{"award-number":["K23HD096018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI084011"],"award-info":[{"award-number":["R01AI084011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100000030","name":"U.S. Department of Health & Human Services | Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30120C07725"],"award-info":[{"award-number":["75D30120C07725"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neutralization capacity of antibodies against Omicron after a prior SARS-CoV-2 infection in children and adolescents is not well studied. Therefore, we evaluated virus-neutralizing capacity against SARS-CoV-2 Alpha, Beta, Gamma, Delta and Omicron variants by age-stratified analyses (&lt;5, 5\u201311, 12\u201321 years) in 177 pediatric patients hospitalized with severe acute COVID-19, acute MIS-C, and in convalescent samples of outpatients with mild COVID-19 during 2020 and early 2021. Across all patients, less than 10% show neutralizing antibody titers against Omicron. Children &lt;5 years of age hospitalized with severe acute COVID-19 have lower neutralizing antibodies to SARS-CoV-2 variants compared with patients &gt;5 years of age. As expected, convalescent pediatric COVID-19 and MIS-C cohorts demonstrate higher neutralization titers than hospitalized acute COVID-19 patients. Overall, children and adolescents show some loss of cross-neutralization against all variants, with the most pronounced loss against Omicron. In contrast to SARS-CoV-2 infection, children vaccinated twice demonstrated higher titers against Alpha, Beta, Gamma, Delta and Omicron. These findings can influence transmission, re-infection and the clinical disease outcome from emerging SARS-CoV-2 variants and supports the need for vaccination in children.<\/jats:p>","DOI":"10.1038\/s41467-022-30649-1","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T10:03:49Z","timestamp":1653645829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C"],"prefix":"10.1038","volume":"13","author":[{"given":"Juanjie","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7115-7545","authenticated-orcid":false,"given":"Tanya","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-9535","authenticated-orcid":false,"given":"Gabrielle","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema Tuz","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Bellusci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pourhashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Moffitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha B.","family":"Halasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracie C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko M.","family":"Tarquinio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3351-3278","authenticated-orcid":false,"given":"Matt S.","family":"Zinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Staat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira J.","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie Z.","family":"Cvijanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Loftis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bria M.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8111-3215","authenticated-orcid":false,"given":"Katherine","family":"Irby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1393-6476","authenticated-orcid":false,"given":"Courtney M.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi R.","family":"Flori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline B.","family":"Maddux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3382-5159","authenticated-orcid":false,"given":"Steven L.","family":"Shein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5392-8457","authenticated-orcid":false,"given":"Hillary","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet R.","family":"Hume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte V.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-2699","authenticated-orcid":false,"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina R.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Kyung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-3071","authenticated-orcid":false,"given":"Adrienne G.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-7965","authenticated-orcid":false,"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"30649_CR1","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim, S. S. A. & Karim, Q. A. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398, 2126\u20132128 (2021).","journal-title":"Lancet"},{"key":"30649_CR2","doi-asserted-by":"publisher","unstructured":"Chen J., Wang R., Gilby N. B. & Wei G. W. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. ArXiv https:\/\/doi.org\/10.48550\/arXiv.2112.01318 (2021).","DOI":"10.48550\/arXiv.2112.01318"},{"key":"30649_CR3","doi-asserted-by":"publisher","unstructured":"Cele, S. et al. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv https:\/\/doi.org\/10.1101\/2021.12.08.21267417 (2021).","DOI":"10.1101\/2021.12.08.21267417"},{"key":"30649_CR4","doi-asserted-by":"publisher","first-page":"o110","DOI":"10.1136\/bmj.o110","volume":"376","author":"I Torjesen","year":"2022","unstructured":"Torjesen, I. Covid-19: omicron variant is linked to steep rise in hospital admissions of very young children. BMJ 376, o110 (2022).","journal-title":"BMJ"},{"key":"30649_CR5","doi-asserted-by":"crossref","unstructured":"Elliott, P. et al. Rapid increase in omicron infections in england during December 2021: REACT-1 study. Science 375, 1406\u20131411 (2022).","DOI":"10.1126\/science.abn8347"},{"key":"30649_CR6","doi-asserted-by":"crossref","unstructured":"Bittmann, S. Role of omicron variant of SARS-CoV-2 in children in Germany. World J. Pediatr. 18, 283\u2013284 (2022).","DOI":"10.1007\/s12519-021-00511-3"},{"key":"30649_CR7","doi-asserted-by":"publisher","first-page":"825256","DOI":"10.3389\/fimmu.2022.825256","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu, H., Wei, P., Kappler, J. W., Marrack, P. & Zhang, G. SARS-CoV-2 Variants Of Concern And Variants Of Interest Receptor Binding Domain Mutations And Virus Infectivity. Front. Immunol. 13, 825256 (2022).","journal-title":"Front. Immunol."},{"key":"30649_CR8","doi-asserted-by":"crossref","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 7898, 671\u2013675 (2021).","DOI":"10.1038\/s41586-021-04389-z"},{"key":"30649_CR9","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the omicron variant of SARS-CoV-2. Nature, 602, 676\u2013681 (2021).","DOI":"10.1038\/s41586-021-04388-0"},{"key":"30649_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jama.2021.21625","volume":"327","author":"M Suran","year":"2022","unstructured":"Suran, M. Why parents still hesitate to vaccinate their children against COVID-19. JAMA 327, 23\u201325 (2022).","journal-title":"JAMA"},{"key":"30649_CR11","doi-asserted-by":"publisher","unstructured":"Truong, T. T. et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv https:\/\/doi.org\/10.1101\/2021.02.27.21252099 (2021).","DOI":"10.1101\/2021.02.27.21252099"},{"key":"30649_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1126\/science.abd7672","volume":"370","author":"R Laxminarayan","year":"2020","unstructured":"Laxminarayan, R. et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science 370, 691\u2013697 (2020).","journal-title":"Science"},{"key":"30649_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/22221751.2022.2035195","volume":"11","author":"LL Chen","year":"2022","unstructured":"Chen, L. L. et al. Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine. Emerg. Microbes Infect. 11, 543\u2013547 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"30649_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-021-01089-8","volume":"23","author":"AC Dowell","year":"2022","unstructured":"Dowell, A. C. et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 23, 40\u201349 (2022).","journal-title":"Nat. Immunol."},{"key":"30649_CR15","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","volume":"184","author":"D Zhou","year":"2021","unstructured":"Zhou, D. et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell 184, 2348\u20132361.e2346 (2021).","journal-title":"Cell"},{"key":"30649_CR16","doi-asserted-by":"crossref","unstructured":"Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602, 654\u2013656 (2021).","DOI":"10.1038\/s41586-021-04387-1"},{"key":"30649_CR17","doi-asserted-by":"publisher","first-page":"103006","DOI":"10.1016\/j.isci.2021.103006","volume":"24","author":"J Tang","year":"2021","unstructured":"Tang, J. et al. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience 24, 103006 (2021).","journal-title":"iScience"},{"key":"30649_CR18","doi-asserted-by":"publisher","first-page":"eabc3539","DOI":"10.1126\/scitranslmed.abc3539","volume":"12","author":"S Ravichandran","year":"2020","unstructured":"Ravichandran, S. et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci. Transl. Med. 12, eabc3539 (2020).","journal-title":"Sci. Transl. Med."},{"key":"30649_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","volume":"602","author":"M Yoshida","year":"2022","unstructured":"Yoshida, M. et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 602, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"30649_CR20","doi-asserted-by":"crossref","unstructured":"Nguyen-Contant, P. et al. S protein-reactive IgG and memory B cell production after human SARS-CoV-2 infection includes broad reactivity to the S2 subunit. mBio 11, e01991-20 (2020).","DOI":"10.1128\/mBio.01991-20"},{"key":"30649_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21463-2","volume":"12","author":"J Tang","year":"2021","unstructured":"Tang, J. et al. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients. Nat. Commun. 12, 1221 (2021).","journal-title":"Nat. Commun."},{"key":"30649_CR22","doi-asserted-by":"crossref","unstructured":"Ravichandran, S. et al. Longitudinal antibody repertoire in \u201cmild\u201d versus \u201csevere\u201d COVID-19 patients reveals immune markers associated with disease severity and resolution. Sci. Adv. 7, eabf2467 (2021).","DOI":"10.1126\/sciadv.abf2467"},{"key":"30649_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41590-021-01051-8","volume":"22","author":"S Ravichandran","year":"2021","unstructured":"Ravichandran, S. et al. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nat. Immunol. 22, 1452\u20131464 (2021).","journal-title":"Nat. Immunol."},{"key":"30649_CR24","unstructured":"Shrock, E. et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science 370, eabd4250 (2020)."},{"key":"30649_CR25","doi-asserted-by":"publisher","first-page":"e0256482","DOI":"10.1371\/journal.pone.0256482","volume":"16","author":"SA Lapp","year":"2021","unstructured":"Lapp, S. A. et al. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection. PLoS ONE 16, e0256482 (2021).","journal-title":"PLoS ONE"},{"key":"30649_CR26","doi-asserted-by":"publisher","unstructured":"Mallapaty, S. COVID reinfections surge during Omicron onslaught. Nature https:\/\/doi.org\/10.1038\/d41586-022-00438-3 (2022).","DOI":"10.1038\/d41586-022-00438-3"},{"key":"30649_CR27","unstructured":"CDC U. COVID-19 DATA TRACKER. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/covidview\/index.html (2022)."},{"key":"30649_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2116298","volume":"386","author":"EB Walter","year":"2022","unstructured":"Walter, E. B. et al. Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 Years of Age. New Engl. J. Med. 386, 35\u201346 (2022).","journal-title":"New Engl. J. Med."},{"key":"30649_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","volume":"71","author":"LD Zambrano","year":"2022","unstructured":"Zambrano, L. D. et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years - United States, July-December 2021. Morb. Mortal. Wkly Rep. 71, 52\u201358 (2022).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"30649_CR30","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.15585\/mmwr.mm7042e1","volume":"70","author":"SM Olson","year":"2021","unstructured":"Olson, S. M. et al. Effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12-18 years - United States, June-September 2021. Morb. Mortal. Wkly Rep. 70, 1483\u20131488 (2021).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"30649_CR31","doi-asserted-by":"publisher","first-page":"e2116420","DOI":"10.1001\/jamanetworkopen.2021.16420","volume":"4","author":"AB Payne","year":"2021","unstructured":"Payne, A. B. et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw. Open 4, e2116420 (2021).","journal-title":"JAMA Netw. Open"},{"key":"30649_CR32","unstructured":"Feldstein, L. R. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. New Engl. J. Med. 383, 334\u2013346 (2020)."},{"key":"30649_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/PCC.0000000000000661","volume":"17","author":"AG Randolph","year":"2016","unstructured":"Randolph, A. G. et al. Optimizing virus identification in critically Ill children suspected of having an acute severe viral infection. Pediatr. Crit. Care Med. 17, 279\u2013286 (2016).","journal-title":"Pediatr. Crit. Care Med."},{"key":"30649_CR34","doi-asserted-by":"publisher","first-page":"e0248348","DOI":"10.1371\/journal.pone.0248348","volume":"16","author":"SN Neerukonda","year":"2021","unstructured":"Neerukonda, S. N. et al. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2. PLoS ONE 16, e0248348 (2021).","journal-title":"PLoS ONE"},{"key":"30649_CR35","doi-asserted-by":"crossref","unstructured":"Ravichandran, S. et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci. Transl. Med. 12, eabc3539 (2020).","DOI":"10.1126\/scitranslmed.abc3539"},{"key":"30649_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/gepi.22268","volume":"44","author":"J Hecker","year":"2020","unstructured":"Hecker, J. et al. A flexible and nearly optimal sequential testing approach to randomized testing: QUICK-STOP. Genet Epidemiol. 44, 139\u2013147 (2020).","journal-title":"Genet Epidemiol."}],"updated-by":[{"DOI":"10.1038\/s41467-022-32572-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30649-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30649-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30649-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:23:39Z","timestamp":1669310619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30649-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30649"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30649-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-022-32572-x","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-022-32572-x","URL":"https:\/\/doi.org\/10.1038\/s41467-022-32572-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.H. received grant support from Sanofi and Quidel Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Antibody assays were performed with approval from the U.S. Food and Drug Administration\u2019s Research Involving Human Subjects Committee (FDA-RIHSC) under exemption protocol \u2018252-Determination- CBER-2020-08-19. All assays performed fell within the permissible usages in the original consent. Study pediatric sites relied on a single IRB at Boston Children\u2019s Hospital and informed consent was obtained from at least one parent or legal guardian when possible, or consent was waived for deidentified samples from clinical discards. Vaccinated healthy control samples from University of California San Diego (UCSD) were obtained following parental and subject consent and assent as appropriate. The protocol was approved by the IRB at UCSD (#140220).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2979"}}